CIK 0000897448
- Accelerated filer
AMARIN CORP PLCUK
Sign in to watch- Ticker
- AMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- Operating
- Phone
- +353 16699020
- Business address
- SPACES SOUTH DOCKLANDS, BLOCK C, 77 SIR JOHN ROGERSON'S QUAY, DUBLIN 2, Ireland
- Former names
- AMARIN CORP PLC\UK, AMARIN PHARMACEUTICALS PLC, ETHICAL HOLDINGS PLC
- 4 Open-market sale SVP and CFO sold 200,000 shares at $15.26 ($3,051,080)
- 4 Open-market sale Director sold 140,416 shares at an average $17.28 ($2,426,489)
- 4 Open-market sale Director sold 526,500 shares at an average $13.07 ($6,882,371)
- 4 Open-market sale General Counsel sold 26,943 shares at $13.49 ($363,547)
- 4 Open-market sale Chief Scientific Officer sold 17,041 shares at $13.51 ($230,212)
- 4 Shares withheld for taxes President and CEO gave up 14,757 shares (to pay taxes)
- 4 Open-market sale Chief Scientific Officer sold 17,042 shares at $17.79 ($303,174)
- 4 Open-market sale General Counsel sold 23,306 shares at $17.81 ($414,998)
- 4 Open-market sale President and CEO sold 607,611 shares at an average $19.07 ($11,587,896)
- 4 Open-market sale Chief Scientific Officer sold 17,042 shares at an average $20.74 ($353,454)
- 4 Open-market sale General Counsel sold 23,307 shares at an average $20.74 ($483,362)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes President and CEO gave up 14,757 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Scientific Officer sold 316,604 shares at an average $16.13 ($5,105,589)
- 4 Open-market sale General Counsel sold 50,249 shares at an average $16.81 ($844,528)
- 4 Derivatives Options or other derivatives
Page 18 of 31 · 620 filings